56 related articles for article (PubMed ID: 9315418)
1. Successful postcoital testing of Ovaprene: An investigational non-hormonal monthly vaginal contraceptive.
Mauck C; Thurman A; Jensen JT; Schreiber CA; Baker J; Hou MY; Chavoustie S; Dart C; Wu H; Zack N; Hatheway J; Friend D
Contraception; 2024 Apr; 132():110373. PubMed ID: 38232942
[TBL] [Abstract][Full Text] [Related]
2. Safety testing of Ovaprene: An investigational nonhormonal monthly vaginal contraceptive.
Mauck C; Thurman A; Jensen JT; Schreiber CA; Baker J; Hou MY; Chavoustie S; Dart C; Wu H; Ravel J; Gajer P; Herold BC; Jacot T; Zack N; Hatheway J; Friend D
Contraception; 2024 Jul; 135():110440. PubMed ID: 38552818
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography compared with colposcopy for assessment of vaginal epithelial damage: a randomized controlled trial.
Vincent KL; Stanberry LR; Moench TR; Breitkopf CR; Loza ML; Wei J; Grady J; Paull J; Motamedi M; Rosenthal SL
Obstet Gynecol; 2011 Dec; 118(6):1354-1361. PubMed ID: 22105265
[TBL] [Abstract][Full Text] [Related]
4. Safety of multiple administrations of spermicidal LL-37 antimicrobial peptide into the mouse female reproductive tract.
Lee SG; Kiattiburut W; Burke Schinkel SC; Angel J; Tanphaichitr N
Mol Hum Reprod; 2023 Jun; 29(7):. PubMed ID: 37326833
[TBL] [Abstract][Full Text] [Related]
5. In vivo effects of nonoxynol-9 on endometrial immune cell populations.
Rahangdale L; Greenblatt RM; Perry J; Darragh TM; Kobayashi A; Smith-McCune KK
J Acquir Immune Defic Syndr; 2009 Sep; 52(1):137-9. PubMed ID: 19704265
[No Abstract] [Full Text] [Related]
6. A nine-month repeat-dose intravaginal ring (Ovaprene) irritation study in sheep.
Davis S; Parthun K; Friend DR
Contraception; 2024 May; 133():110387. PubMed ID: 38342425
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a Triticum vulgare Extract as a Treatment of Cervical Ectropion: A Prospective Observational Cohort Study.
Manna P; Gallo A; Bitonti G; Venturella R; Di Carlo C
J Low Genit Tract Dis; 2024 Apr; ():. PubMed ID: 38661363
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin in cervical mucus as a biochemical marker for inflammation.
Mania-Pramanik J; Mali BN; Shah RS; Donde UM
Indian J Clin Biochem; 1999 Jul; 14(2):229-36. PubMed ID: 23105223
[TBL] [Abstract][Full Text] [Related]
9. Characterization of commercially available vaginal lubricants: a safety perspective.
Cunha AR; Machado RM; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; das Neves J; Palmeira-de-Oliveira R
Pharmaceutics; 2014 Sep; 6(3):530-42. PubMed ID: 25247884
[TBL] [Abstract][Full Text] [Related]
10. Surfing a shallow wave? Improving the scientific foundations for new contraceptive compounds targeting sperm in the human female reproductive tract.
Gellatly SA; Eisenberg ML; Barratt CLR
Fertil Steril; 2024 Apr; ():. PubMed ID: 38614454
[No Abstract] [Full Text] [Related]
11. ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.
Thurman AR; Moench TR; Hoke M; Politch JA; Cabral H; Mausser E; Nador E; Morton J; Hamorsky K; Swope K; Bratcher B; Anderson DJ; Whaley KJ
Am J Obstet Gynecol; 2023 Jun; 228(6):716.e1-716.e12. PubMed ID: 36870409
[TBL] [Abstract][Full Text] [Related]
12. Effects of nonoxynol-9 (N-9) on sperm functions: systematic review and meta-analysis.
Xu M; Zhao M; Li RHW; Lin Z; Chung JPW; Li TC; Lee TL; Chan DYL
Reprod Fertil; 2022 Jan; 3(1):R19-R33. PubMed ID: 35350652
[TBL] [Abstract][Full Text] [Related]
13. The postcoital test in the development of new vaginal contraceptives†.
Mauck CK; Vincent KL
Biol Reprod; 2020 Aug; 103(2):437-444. PubMed ID: 32657328
[TBL] [Abstract][Full Text] [Related]
14. L-selectin and P-selectin are novel biomarkers of cervicovaginal inflammation for preclinical mucosal safety assessment of anti-HIV-1 microbicide.
Zhong M; He B; Yang J; Bao R; Zhang Y; Zhou D; Chen Y; Li L; Han C; Yang Y; Sun Y; Cao Y; Li Y; Shi W; Jiang S; Zhang X; Yan H
Antimicrob Agents Chemother; 2012 Jun; 56(6):3121-32. PubMed ID: 22391529
[TBL] [Abstract][Full Text] [Related]
15. Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations.
Harwood B; Meyn LA; Ballagh SA; Raymond EG; Archer DF; Creinin MD
Am J Obstet Gynecol; 2008 Jan; 198(1):32.e1-7. PubMed ID: 18166301
[TBL] [Abstract][Full Text] [Related]
16. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
[TBL] [Abstract][Full Text] [Related]
17. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Abercrombie TJ; Archer DF
Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
[TBL] [Abstract][Full Text] [Related]
18. A phase I study of Femcap used with and without spermicide. Postcoital testing.
Mauck CK; Baker JM; Barr SP; Johanson W; Archer DF
Contraception; 1997 Aug; 56(2):111-5. PubMed ID: 9315420
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
